Orphan Drugs Market - Company Profile (AbbVie Inc., Aegerion Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Pfizer Inc. and Sanofi.)and Competitive intelligence report 2017

TOC

Chapter: 1 COMPANY PROFILES

1.1. ABBVIE INC.

1.1.1. Company overview

1.1.2. Company snapshot

1.1.3. Operating business segments

1.1.4. Product portfolio

1.1.5. Business performance

1.1.6. Key strategic moves and developments

1.2. AEGERION PHARMACEUTICALS, INC. (NOVELION THERAPEUTICS INC.)

1.2.1. Company overview

1.2.2. Company snapshot

1.2.3. Operating business segments

1.2.4. Product portfolio

1.2.5. Business performance

1.2.6. Key strategic moves and developments

1.3. BRISTOL-MYERS SQUIBB COMPANY

1.3.1. Company overview

1.3.2. Company snapshot

1.3.3. Operating business segment

1.3.4. Product portfolio

1.3.5. Business performance

1.3.6. Key strategic moves and developments

1.4. CELGENE CORPORATION

1.4.1. Company overview

1.4.2. Company snapshot

1.4.3. Operating business segments

1.4.4. Product portfolio

1.4.5. Business performance

1.4.6. Key strategic moves and developments

1.5. F. HOFFMANN-LA ROCHE AG

1.5.1. Company overview

1.5.2. Company snapshot

1.5.3. Operating business segments

1.5.4. Product portfolio

1.5.5. Business performance

1.5.6. Key strategic moves and developments

1.6. GLAXOSMITHKLINE PLC

1.6.1. Company overview

1.6.2. Company snapshot

1.6.3. Operating business segments

1.6.4. Product portfolio

1.6.5. Business performance

1.6.6. Key strategic moves and developments

1.7. JOHNSON & JOHNSON

1.7.1. Company overview

1.7.2. Company snapshot

1.7.3. Operating business segments

1.7.4. Product portfolio

1.7.5. Business performance

1.7.6. Key strategic moves and developments

1.8. NOVARTIS AG

1.8.1. Company overview

1.8.2. Company snapshot

1.8.3. Operating business segments

1.8.4. Product portfolio

1.8.5. Business performance

1.8.6. Key strategic moves and developments

1.9. PFIZER INC.

1.9.1. Company overview

1.9.2. Company snapshot

1.9.3. Operating business segments

1.9.4. Product portfolio

1.9.5. Business performance

1.9.6. Key strategic moves and developments

1.10. SANOFI

1.10.1. Company overview

1.10.2. Company snapshot

1.10.3. Operating business segments

1.10.4. Product portfolio

1.10.5. Business performance

1.10.6. Key strategic moves and developments

LIST OF TABLES AND FIGURES

TABLE 1. ABBVIE: COMPANY SNAPSHOT

TABLE 2. ABBVIE: OPERATING SEGMENTS

TABLE 3. ABBVIE: OPERATING SEGMENTS

TABLE 4. AEGERION PHARMACEUTICALS: COMPANY SNAPSHOT

TABLE 5. AEGERION PHARMACEUTICALS: OPERATING SEGMENTS

TABLE 6. AEGERION PHARMACEUTICALS: OPERATING SEGMENTS

TABLE 7. BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT

TABLE 8. BRISTOL-MYERS SQUIBB: OPERATING SEGMENTS

TABLE 9. BRISTOL-MYERS SQUIBB: PRODUCT PORTFOLIO

TABLE 10. CELGENE: COMPANY SNAPSHOT

TABLE 11. CELGENE: OPERATING SEGMENTS

TABLE 12. CELGENE: PRODUCT PORTFOLIO

TABLE 13. ROCHE: COMPANY SNAPSHOT

TABLE 14 ROCHE: OPERATING SEGMENT

TABLE 15. ROCHE: PRODUCT PORTFOLIO

TABLE 16. GSK: COMPANY SNAPSHOT

TABLE 17. GSK: OPERATING SEGMENTS

TABLE 18. GSK: PRODUCT PORTFOLIO

TABLE 19. J&J: COMPANY SNAPSHOT

TABLE 20. J&J: OPERATING SEGMENTS

TABLE 21. J&J: PRODUCT PORTFOLIO

TABLE 22. NOVARTIS: COMPANY SNAPSHOT

TABLE 23. NOVARTIS: OPERATING SEGMENTS

TABLE 24. NOVARTIS: PRODUCT PORTFOLIO

TABLE 25. PFIZER: COMPANY SNAPSHOT

TABLE 26. PFIZER: OPERATING SEGMENTS

TABLE 27. PFIZER: PRODUCT CATEGORY

TABLE 28. SANOFI: COMPANY SNAPSHOT

TABLE 29. SANOFI: OPERATING SEGMENTS

TABLE 30.. SANOFI: PRODUCT PORTFOLIO